Abstract:Background & aims: Guidelines on clinical nutrition recommend the use of appropriate nutritional support therapy for surgical cancer patients at risk of malnutrition both during hospital care and following discharge from the hospital. However, previous studies regarding nutritional interventions have mainly focused on patients during their hospital stay; there is limited evidence supporting the recommendation of nutritional interventions for post-discharge patients after cancer surgery, particularly those who underwent gastrointestinal cancer surgery and at high risk of malnutrition. To clearly address this issue, we designed and conducted two independent studies on two different groups of post-discharge patients at nutritional risk after gastrointestinal cancer surgery. The present study aimed to assess the impact of oral nutritional supplements (ONS) in post-discharge patients at nutritional risk following colorectal cancer surgery. Meanwhile, the sister study on the use of ONS in post-discharge patients following gastric cancer surgery will be reported separately. Methods: Between January 2017 and June 2019, post-discharge patients following colorectal cancer surgery in our institution were randomised to receive either dietary advice alone (control group) or dietary advice in combination with ONS (ONS group) for three months if they were at nutritional risk based on the tool of Nutritional Risk Screening 2002. The primary endpoints were nutritional outcomes and sarcopenia prevalence. The secondary endpoints were 90-day readmission rate, chemotherapy tolerance, and quality of life (QoL). Results: Of the 232 eligible patients, 212 (107 in the control group and 105 in the ONS group) completed the trial. Their data were then analyzed. The mean ONS intake was 410 mL every day. By the three-month intervention, the skeletal muscle index in the ONS group was significantly higher than that in the control group (39.75 +/- 5.83 vs 38.01 +/- 6.18 cm(2)/m(2), P = 0.037), but no significant differences between the two groups were noted in weight, weight loss, body mass index, serum albumin and hemoglobin (P > 0.05). In addition, the ONS group had a significantly lower sarcopenia prevalence (28.6% vs 42.1%, P = 0.040). No significant difference between the two groups was found in the 90-day readmission rate (P > 0.05). The number of patients undergoing postoperative chemotherapy in the two groups was similar, but chemotherapy modifications, such as delay, dose reduction, or termination, were significantly reduced in the ONS group (21.2% vs 36.8%, P=0.024). However, ONS had no significant effect on QoL (P > 0.05). Conclusions: In post-discharge patients at nutritional risk following colorectal cancer surgery, the use of ONS may reduce skeletal muscle loss and sarcopenia prevalence, as well as improve chemotherapy tolerance, compared with dietary advice alone. These findings underline the importance of ONS treatment in post-discharge patients at nutritional risk following colorectal cancer surgery. (C) 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

A clinical study on nutritional supplementation of injectile fructose in surgical patients of gastrointestinal malignancies

Effects of different postoperative nutritional support on oxidative stress and clinical outcomes for patients after gastrointestinal surgery

Effects of Enteral Nutrition Preparations on Glucose and Lipid Metabolism in Elderly Diabetic Patients

A more physiological feeding process in ICU: Intermittent infusion with semi-solid nutrients (CONSORT-compliant).

Clinical Study of Fructose on Blood Glucose of Diabetes Mellitus

Efficacy of the Oral Administration of Maltodextrin Fructose Before Major Abdominal Surgery: A Prospective, Multicenter Clinical Study

Perioperative Artificial Nutrition in Malnourished Gastrointestinal Cancer Patients

A Randomized Controlled Trial of Postoperative Artificial Nutrition in Malnourished Patients with Gastrointestinal Cancer

Preoperative Carbohydrate Loading in Diabetic Patients Undergoing Gastrointestinal Surgery: A Pilot Randomized Trial

Effect of oligofructose on resistance to postoperative high-fat diet-induced damage of metabolism in diabetic rats after sleeve gastrectomy

Preoperative Carbohydrate Loading with Individualized Supplemental Insulin in Diabetic Patients Undergoing Gastrointestinal Surgery: A Randomized Trial

Clinical Study on Safety and Efficacy of Enteral Nutritional Suspension in Patients after Abdominal Operations

Application of parenteral nutrition with fructose-1,6-diphosphate in elder abdominal operative patients

Metabolic Studies in Gastrointestinal Cancer Patients Before and after Surgery

Preoperative Oral Carbohydrate Administration Can Ameliorate Perioperative Stress and Metabolism for Patients with Surgical Thoracic Oncology

Impact of Oral Nutritional Supplements in Post-Discharge Patients at Nutritional Risk Following Colorectal Cancer Surgery: A Randomised Clinical Trial

A survey of nutritional support in gastrointestinal cancer patients

[Metabolic behavior in pre, intra, and postoperative total parenteral feeding with a carbohydrate combination and amino acid solution]

Influence of different enteral nutritional support regimens on the nutritional status of post-operative patients with gastric cancer

Effect of surgical stress on plasma glucagon-like peptide 1 level after enternal or parenteral intake of glucose in surgical critically ill patients

Nutritional risk and nutritional support in gastrointestinal cancer surgical patients